Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review.
about
Prevalence of familial hypercholesterolemia: a meta-analysis of six large, observational, population-based studies in PolandThe genetics and screening of familial hypercholesterolaemiaFamilial hypercholesterolemia: Review of diagnosis, screening, and treatmentOptimizing Treatment of Familial Hypercholesterolemia in Children and AdolescentsLow-density lipoprotein cholesterol, apolipoprotein B, and risk of coronary heart disease: from familial hyperlipidemia to genomicsFamilial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis SocietyCriteria for Diagnosis of Familial Hypercholesterolemia: A Comprehensive Analysis of the Different Guidelines, Appraising their Suitability in the Omani Arab PopulationSortilin, encoded by the cardiovascular risk gene SORT1, and its suggested functions in cardiovascular diseaseNovel and recurrent LDLR gene mutations in Pakistani hypercholesterolemia patients.Mutation in the PCSK9 Gene in Omani Arab Subjects with Autosomal Dominant Hypercholesterolemia and its Effect on PCSK9 Protein StructureGenetic Architecture of Familial Hypercholesterolaemia.Enhanced status of inflammation and endothelial activation in subjects with familial hypercholesterolaemia and their related unaffected family members: a case control studyPCSK9 inhibitor access barriers-issues and recommendations: Improving the access process for patients, clinicians and payers.Screening strategies for cardiovascular disease in asymptomatic adults.Efficacy and safety of proprotein convertase subtilisin/kexin type 9 monoclonal antibody in adults with familial hypercholesterolemiaAnalysis of sequence variations in low-density lipoprotein receptor gene among Malaysian patients with familial hypercholesterolemia.Heterozygous Familial Hypercholesterolemia With APOE Haplotype: A Prospective Harbinger of a Catastrophic Cardiovascular Event.Cascade Screening for Familial Hypercholesterolemia (FH)Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society.Children and young adults with familial hypercholesterolaemia (FH) have healthier food choices particularly with respect to dietary fat sources compared with non-FH childrenDifferential impact of familial hypercholesterolemia and combined hyperlipidemia on vascular wall and network remodeling in mice.LDLR promoter variant and exon 14 mutation on the same chromosome are associated with an unusually severe FH phenotype and treatment resistance.LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectivesHeterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular disease.Whole-exome sequencing in an extended family with myocardial infarction unmasks familial hypercholesterolemia.Genetic polymorphisms in LDLR, APOB, PCSK9 and other lipid related genes associated with familial hypercholesterolemia in Malaysia.Founder mutations in the Netherlands: geographical distribution of the most prevalent mutations in the low-density lipoprotein receptor and apolipoprotein B genesFunctional characterization of two low-density lipoprotein receptor gene mutations in two Chinese patients with familial hypercholesterolemia.Familial Hypercholesterolemia: a Review of the Natural History, Diagnosis, and ManagementA model of care for familial hypercholesterolaemia: key role for clinical biochemistry.Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL-C levels in a latvian populationCellular cholesterol efflux and cholesterol loading capacity of serum: effects of LDL-apheresis.Pharmacoeconomics of PCSK9 inhibitors in 103 hypercholesterolemic patients referred for diagnosis and treatment to a cholesterol treatment center.Atherosclerotic and thrombotic genetic and environmental determinants in Egyptian coronary artery disease patients: a pilot study.Genetics, genomics and proteomics in atherosclerosis research.Dyslipidemia in the Arabian Gulf and its Impact on Cardiovascular Risk OutcomeReducing the burden of disease and death from familial hypercholesterolemia: a call to actionSystematic analysis of variants related to familial hypercholesterolemia in families with premature myocardial infarctionThe PCSK9 Inhibitors: A Novel Therapeutic Target Enters Clinical Practice.The genetic spectrum of familial hypercholesterolemia in south-eastern Poland.
P2860
Q26740377-D4F26C0C-DD55-4FEA-BDFF-01F5621B8753Q26753081-67D35AA3-0720-41E8-A883-D8C664330CC5Q26770143-28A33774-8358-4EAA-9FF4-E995BDCF8529Q26798119-FA8E71D8-25D2-4777-855E-C74A4C1C1E22Q26853114-BCD84872-7ED3-4822-BD2A-7F8473EB48AAQ27024882-2586EA2B-09FE-4BA9-97B2-342644024C88Q27025178-3AD1C281-06E2-474B-8D45-4E74DD8CCCB8Q28257511-EC44C21E-085B-4D1E-84AE-C93296934346Q30412645-AAE38CB6-A219-4159-A97C-68F0B94998BCQ30426857-8C0FE9CF-C50E-43DE-96FA-B58522ECBCEFQ33559233-EF962C6A-5452-4355-8B0E-FD88519205AFQ33601191-F6BB4738-DC42-45ED-8121-2AA1E233DCF6Q33625574-FE1BABA0-921F-40D3-95CF-0304E17B7667Q33704011-2D00DD2E-9EC5-481E-B7CC-037456AF3A96Q33728343-8CC6FC77-A36A-4AF5-9B26-C16500E57358Q33850303-BD297D67-0E09-457A-9727-94EB94C77A4CQ33893915-CC2946EB-EF4E-4A5B-A5B9-120D3925AC2FQ33919782-79D8AC83-4CE4-43AB-88CC-5F5BF3F76245Q34071937-C9EC7813-734C-4798-BC0C-D11515BD3575Q34126112-4BD86608-E75C-4C17-8CF1-B60232D666DFQ34189171-B9E0CAF6-1631-4299-874F-5FB5244EA1FAQ34325396-DCE94B89-365E-45AC-A9AE-0E653DD15740Q34467839-8FF4CF80-276A-4904-93B6-691EF3C25225Q34499298-CF5DAE44-BA94-47FB-8DD5-5E4F877DAE3CQ34569742-0C0886E8-3C68-4778-90FA-3BD7ED0E3210Q34673986-1F11FEBC-C4AC-46A6-8AB9-B6344CD4D283Q34679770-9C1D56C2-5556-41A1-B067-10DD5E973B9AQ35132267-CDC61D01-3467-4F6B-B89F-39C814FCB6ECQ35756629-474D13BA-5263-4DF4-9702-B7CECB4C5806Q35771729-4A740CCB-AC04-4CB0-A918-B3FF0C9007F2Q35790784-49F2FBD4-A623-4383-B885-7179881FC15AQ35897068-DF138D8D-7C59-4D88-B0E8-B595F248A9EDQ36107244-25ADD4D6-1B06-4337-8249-D85F5A953987Q36249248-3C622A44-8FC5-47DD-92F6-DF5FF39AEC67Q36265225-7E32FA29-565F-487F-B798-854F0A6AD669Q36373684-1B4AB314-EC3D-422A-8301-2F1071E014E8Q36381467-484CB8CD-6916-4336-86C2-04A730EA630DQ36474966-B9A9C6B0-B64C-46DB-AFF9-0AAF9CF8DD74Q36480595-A899E78C-EE96-486F-9D49-B6F3DDE4DF36Q36615448-83F33334-813A-49BC-AF1A-D3D305EEBBDB
P2860
Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Genetic causes of monogenic he ...... mia: a HuGE prevalence review.
@ast
Genetic causes of monogenic he ...... mia: a HuGE prevalence review.
@en
type
label
Genetic causes of monogenic he ...... mia: a HuGE prevalence review.
@ast
Genetic causes of monogenic he ...... mia: a HuGE prevalence review.
@en
prefLabel
Genetic causes of monogenic he ...... mia: a HuGE prevalence review.
@ast
Genetic causes of monogenic he ...... mia: a HuGE prevalence review.
@en
P2093
P356
P1476
Genetic causes of monogenic he ...... mia: a HuGE prevalence review.
@en
P2093
Carolyn M Hutter
Melissa A Austin
Ron L Zimmern
Steve E Humphries
P304
P356
10.1093/AJE/KWH236
P407
P577
2004-09-01T00:00:00Z